Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Health Research Institutes, Taiwan
ClinicalTrials.gov Identifier:
NCT00201357
First received: September 13, 2005
Last updated: March 23, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2004
  Primary Completion Date: July 2004 (Final data collection date for primary outcome measure)